Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Corvus Pharmaceuticals Inc buy Cantor Fitzgerald

Corvus Pharmaceuticals Inc
Start price
€1.51
07.09.23 / 50%
Target price
€3.74
07.09.24
Performance (%)
-4.11%
Price
€1.56
03.05.24
Summary
This prediction is currently active. With a performance of -4.11%, the BUY prediction for Corvus Pharmaceuticals Inc by Cantor_Fitzgerald is down slightly. This prediction currently runs until 07.09.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Corvus Pharmaceuticals Inc 17.976% 17.976%
iShares Core DAX® -0.922% -1.078%
iShares Nasdaq 100 0.371% -0.556%
iShares Nikkei 225® 2.224% -2.825%
iShares S&P 500 -0.026% -0.788%

Comments by Cantor_Fitzgerald for this prediction

In the thread Corvus Pharmaceuticals Inc diskutieren
Prediction Buy
Perf. (%) -4.11%
Target price 3.739
Change
Ends at 07.09.24

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $4.00 price target on the stock.
Ratings data for CRVS provided by MarketBeat

Cantor Fitzgerald 
0
Report Share
07.09.23

Stopped prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc

buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.67
01.04.24
-
01.04.25
-13.50%
03.05.24

Cantor Fitzgerald 
01.04.24 50%